Literature DB >> 27040419

Traditional Chinese medicine valuably augments therapeutic options in the treatment of climacteric syndrome.

Sarah Eisenhardt1,2, Johannes Fleckenstein3,4.   

Abstract

Climacteric syndrome refers to recurring symptoms such as hot flashes, chills, headache, irritability and depression. This is usually experienced by menopausal women and can be related to a hormonal reorganization in the hypothalamic-pituitary-gonadal axis. In Traditional Chinese Medicine, originating 1000s of years ago, above-mentioned symptoms can be interpreted on the basis of the philosophic diagnostic concepts, such as the imbalance of Yin and Yang, the Zang-Fu and Basic substances (e.g. Qi, Blood and Essence). These concepts postulate balance and harmonization as the principle aim of a treatment. In this context, it is not astounding that one of the most prominent ancient textbooks dating back to 500-200 BC, Huang di Neijing: The Yellow Emperor's Classic of Internal Medicine gives already first instructions for diagnosis and therapy of climacteric symptoms. For therapy, traditional Chinese medicine comprises five treatment principles: Chinese herbal medicine, TuiNa (a Chinese form of manual therapy), nutrition, activity (e.g. QiGong) and acupuncture (being the most widespread form of treatment used in Europe). This review provides an easy access to the concepts of traditional Chinese medicine particularly regarding to climacteric syndrome and also focuses on current scientific evidence.

Entities:  

Keywords:  Acupuncture; Chinese herbal medicine (CHM); Heat flush; Hormone therapy; Integrative medicine; Menopause; Physiologic mechanism; Traditional Chinese medicine (TCM)

Mesh:

Substances:

Year:  2016        PMID: 27040419     DOI: 10.1007/s00404-016-4078-x

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  7 in total

1.  Constitutions of Deficiency and Stasis of Traditional Chinese Medicine and Related Factors among Middle-Aged Women in Taiwan.

Authors:  Ping-Ho Chen; Sheng-Miauh Huang; Jerry Cheng-Yen Lai; Pei-Jung Yu
Journal:  Evid Based Complement Alternat Med       Date:  2020-10-19       Impact factor: 2.629

2.  An evaluation of relugolix/estradiol/norethindrone acetate for the treatment of heavy menstrual bleeding associated with uterine fibroids in premenopausal women.

Authors:  Mohamed Ali; Hsin-Yuan Chen; Yi-Fen Chiang; Osama A Badary; Shih-Min Hsia; Ayman Al-Hendy
Journal:  Expert Opin Pharmacother       Date:  2022-01-24       Impact factor: 3.889

3.  Baicalin Represses C/EBPβ via Its Antioxidative Effect in Parkinson's Disease.

Authors:  Kecheng Lei; Yijue Shen; Yijing He; Liwen Zhang; Jingxing Zhang; Weifang Tong; Yichun Xu; Lingjing Jin
Journal:  Oxid Med Cell Longev       Date:  2020-05-21       Impact factor: 6.543

4.  Xi Lei San Attenuates Dextran Sulfate Sodium-Induced Colitis in Rats and TNF-α-Stimulated Colitis in CACO2 Cells: Involvement of the NLRP3 Inflammasome and Autophagy.

Authors:  Zhang Tao; Xiaoqing Zhou; Yan Zhang; Wenfeng Pu; Yi Yang; Fuxia Wei; Qian Zhou; Lin Zhang; Zhonghan Du; Ji Wu
Journal:  Mediators Inflamm       Date:  2021-04-21       Impact factor: 4.711

5.  Exploring the Molecular Mechanism of Liuwei Dihuang Pills for Treating Diabetic Nephropathy by Combined Network Pharmacology and Molecular Docking.

Authors:  Gaoxiang Wang; Lin Zeng; Qian Huang; Zhaoqi Lu; Ruiqing Sui; Deliang Liu; Hua Zeng; Xuemei Liu; Shufang Chu; Xinhui Kou; Huilin Li
Journal:  Evid Based Complement Alternat Med       Date:  2021-09-13       Impact factor: 2.629

6.  Deciphering the molecular mechanism underlying the effects of epimedium on osteoporosis through system bioinformatic approach.

Authors:  Keliang Wu; Linjing Han; Ying Zhao; Qinghua Xiao; Zhen Zhang; Xiaosheng Lin
Journal:  Medicine (Baltimore)       Date:  2022-08-12       Impact factor: 1.817

7.  Safety of Qigong: Protocol for an overview of systematic reviews.

Authors:  Yu Guo; Mingmin M Xu; Yuchang Huang; Meiqi Ji; Zeren Wei; Jialei Zhang; Qingchuan Hu; Jian Yan; Yue Chen; Jiaxuan Lyu; Xiaoqian Shao; Ying Wang; Jiamei Guo; Yulong Wei
Journal:  Medicine (Baltimore)       Date:  2018-11       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.